Recent improvement in survival outcomes and reappraisal of prognostic factors in hepatoblastoma.

Survival rates were significantly improved in children with hepatoblastoma, especially in those with advanced PRETEXT stages with positive annotation factors and in a high-risk CHIC-HS group. Prognostic factors had different clinical implications with evolved treatment modalities.